Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move?
Catalyst PharmaceuticalsCatalyst Pharmaceuticals(US:CPRX) The Motley Fool·2026-01-01 00:06

The exercise-and-sell transaction came as the rare disease drugmaker reported strong quarterly results. Jeffrey Del Carmen, Chief Commercial Officer of Catalyst Pharmaceuticals (CPRX +0.26%), exercised and immediately sold 10,983 shares of common stock on November 26, 2025, for a total value of approximately 256,200,asdisclosedinthisSECForm4filing.TransactionsummaryMetricValueSharessold10,983Transactionvalue 256,200, as disclosed in this SEC Form 4 filing.Transaction summaryMetricValueShares sold10,983Transaction value~256,200Post-transaction shares3,962Post-transaction value (direct ownership)~$92,800Tra ...